| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ceramides | 43 | 2022 | 578 | 8.240 |
Why?
|
| Sphingosine | 17 | 2021 | 315 | 3.510 |
Why?
|
| Sphingosine N-Acyltransferase | 16 | 2021 | 62 | 3.450 |
Why?
|
| Protein Phosphatase 2 | 8 | 2021 | 67 | 2.740 |
Why?
|
| Membrane Proteins | 13 | 2022 | 617 | 2.660 |
Why?
|
| Lysophospholipids | 11 | 2019 | 209 | 2.210 |
Why?
|
| Apoptosis | 23 | 2022 | 1641 | 2.180 |
Why?
|
| Sphingolipids | 12 | 2022 | 337 | 2.040 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 10 | 2022 | 201 | 1.970 |
Why?
|
| Telomerase | 10 | 2015 | 85 | 1.930 |
Why?
|
| Signal Transduction | 19 | 2021 | 2689 | 1.850 |
Why?
|
| Autophagy | 8 | 2022 | 208 | 1.690 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2021 | 332 | 1.680 |
Why?
|
| Mitochondria | 8 | 2021 | 643 | 1.560 |
Why?
|
| Cell Line, Tumor | 34 | 2021 | 1851 | 1.500 |
Why?
|
| Lung Neoplasms | 9 | 2018 | 1173 | 1.420 |
Why?
|
| Neoplasms | 9 | 2022 | 1667 | 1.380 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2017 | 629 | 1.370 |
Why?
|
| T-Lymphocytes | 9 | 2022 | 597 | 1.210 |
Why?
|
| Oxidoreductases | 8 | 2022 | 117 | 1.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2018 | 30 | 1.060 |
Why?
|
| Telomere | 4 | 2018 | 59 | 1.060 |
Why?
|
| Head and Neck Neoplasms | 6 | 2011 | 561 | 1.050 |
Why?
|
| Mice | 31 | 2022 | 8474 | 1.040 |
Why?
|
| Animals | 43 | 2022 | 20881 | 1.040 |
Why?
|
| Acid Ceramidase | 3 | 2021 | 85 | 1.020 |
Why?
|
| RNA, Small Interfering | 11 | 2016 | 434 | 0.940 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 306 | 0.930 |
Why?
|
| Promoter Regions, Genetic | 5 | 2007 | 615 | 0.920 |
Why?
|
| Stress, Physiological | 4 | 2019 | 215 | 0.900 |
Why?
|
| Mice, SCID | 10 | 2018 | 238 | 0.890 |
Why?
|
| Humans | 83 | 2022 | 68618 | 0.880 |
Why?
|
| Transcription Factors | 4 | 2012 | 753 | 0.870 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 186 | 0.870 |
Why?
|
| Antineoplastic Agents | 7 | 2019 | 1070 | 0.850 |
Why?
|
| Endoplasmic Reticulum | 4 | 2019 | 148 | 0.830 |
Why?
|
| Inflammasomes | 1 | 2022 | 39 | 0.830 |
Why?
|
| Fingolimod Hydrochloride | 4 | 2019 | 24 | 0.830 |
Why?
|
| DNA-Binding Proteins | 9 | 2013 | 700 | 0.820 |
Why?
|
| Graft vs Host Disease | 5 | 2022 | 163 | 0.810 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 113 | 0.780 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2019 | 756 | 0.780 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2013 | 63 | 0.770 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 468 | 0.760 |
Why?
|
| Carrier State | 1 | 2021 | 39 | 0.760 |
Why?
|
| Cell Nucleus | 3 | 2015 | 305 | 0.750 |
Why?
|
| Activating Transcription Factor 6 | 2 | 2011 | 6 | 0.750 |
Why?
|
| Necrosis | 2 | 2018 | 239 | 0.710 |
Why?
|
| Leukemia | 4 | 2022 | 117 | 0.700 |
Why?
|
| Caspase 3 | 3 | 2018 | 233 | 0.700 |
Why?
|
| Doxorubicin | 7 | 2021 | 231 | 0.690 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 116 | 0.670 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 45 | 0.670 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 33 | 0.650 |
Why?
|
| Melanoma | 1 | 2022 | 335 | 0.650 |
Why?
|
| Molecular Docking Simulation | 2 | 2018 | 78 | 0.650 |
Why?
|
| Molecular Motor Proteins | 1 | 2018 | 14 | 0.650 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 49 | 0.640 |
Why?
|
| Mice, Knockout | 9 | 2019 | 1692 | 0.630 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 51 | 0.620 |
Why?
|
| Cell Membrane | 2 | 2018 | 525 | 0.610 |
Why?
|
| Cell Proliferation | 9 | 2018 | 1174 | 0.600 |
Why?
|
| Deoxycytidine | 5 | 2011 | 83 | 0.600 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2017 | 13 | 0.600 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 346 | 0.600 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 56 | 0.590 |
Why?
|
| Cellular Senescence | 1 | 2018 | 112 | 0.580 |
Why?
|
| Propylene Glycols | 3 | 2013 | 16 | 0.570 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2022 | 245 | 0.560 |
Why?
|
| Cilia | 1 | 2017 | 94 | 0.560 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 21 | 0.550 |
Why?
|
| Cisplatin | 1 | 2017 | 192 | 0.550 |
Why?
|
| Histone Chaperones | 3 | 2013 | 11 | 0.540 |
Why?
|
| Piperidines | 1 | 2016 | 123 | 0.530 |
Why?
|
| Drug Resistance, Multiple | 4 | 2000 | 56 | 0.520 |
Why?
|
| Receptors, Lysosphingolipid | 3 | 2019 | 63 | 0.520 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2008 | 123 | 0.510 |
Why?
|
| A549 Cells | 4 | 2019 | 50 | 0.510 |
Why?
|
| Benzimidazoles | 1 | 2016 | 128 | 0.510 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2015 | 20 | 0.510 |
Why?
|
| Aging | 1 | 2021 | 911 | 0.500 |
Why?
|
| Cell Movement | 1 | 2017 | 630 | 0.490 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2013 | 37 | 0.480 |
Why?
|
| MicroRNAs | 3 | 2018 | 447 | 0.480 |
Why?
|
| Tumor Cells, Cultured | 12 | 2018 | 852 | 0.470 |
Why?
|
| Histone Deacetylase 1 | 2 | 2011 | 32 | 0.470 |
Why?
|
| Mutation | 4 | 2016 | 1213 | 0.460 |
Why?
|
| Phosphorylation | 8 | 2017 | 1200 | 0.460 |
Why?
|
| Protein Binding | 7 | 2019 | 1027 | 0.450 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 307 | 0.430 |
Why?
|
| Phagosomes | 1 | 2012 | 19 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2014 | 90 | 0.420 |
Why?
|
| Thioredoxins | 3 | 2019 | 26 | 0.420 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2019 | 304 | 0.420 |
Why?
|
| Veratrum Alkaloids | 1 | 2012 | 3 | 0.410 |
Why?
|
| Pyridines | 4 | 2017 | 261 | 0.410 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 38 | 0.400 |
Why?
|
| Sphingomyelin Phosphodiesterase | 2 | 2012 | 183 | 0.400 |
Why?
|
| Adenocarcinoma | 4 | 2002 | 475 | 0.400 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2009 | 204 | 0.390 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 231 | 0.380 |
Why?
|
| Adamantane | 3 | 2017 | 40 | 0.370 |
Why?
|
| Piperazines | 3 | 2016 | 206 | 0.370 |
Why?
|
| Sp3 Transcription Factor | 2 | 2007 | 4 | 0.360 |
Why?
|
| Nitric Oxide | 1 | 2012 | 382 | 0.350 |
Why?
|
| Pyrimidines | 2 | 2011 | 178 | 0.350 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2022 | 21 | 0.350 |
Why?
|
| Genes, MDR | 2 | 2000 | 9 | 0.340 |
Why?
|
| Transcription Factor CHOP | 1 | 2009 | 28 | 0.340 |
Why?
|
| Ubiquitin | 2 | 2022 | 74 | 0.330 |
Why?
|
| Histone Deacetylases | 2 | 2007 | 99 | 0.330 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 27 | 0.320 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 562 | 0.320 |
Why?
|
| Acetyltransferases | 1 | 2008 | 49 | 0.320 |
Why?
|
| RNA, Messenger | 10 | 2021 | 1664 | 0.310 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 92 | 0.310 |
Why?
|
| RNA | 3 | 2001 | 171 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2019 | 718 | 0.300 |
Why?
|
| Fatty Acids | 1 | 2008 | 222 | 0.300 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 1293 | 0.290 |
Why?
|
| Folic Acid | 2 | 2021 | 123 | 0.290 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2008 | 173 | 0.290 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 2550 | 0.280 |
Why?
|
| Kidney Neoplasms | 2 | 2021 | 206 | 0.280 |
Why?
|
| Transfection | 7 | 2017 | 782 | 0.280 |
Why?
|
| Neuroblastoma | 2 | 2007 | 109 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 194 | 0.270 |
Why?
|
| Colitis | 2 | 2018 | 156 | 0.270 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2006 | 8 | 0.270 |
Why?
|
| Mass Spectrometry | 6 | 2010 | 284 | 0.270 |
Why?
|
| Chromatography, Liquid | 5 | 2021 | 120 | 0.270 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 778 | 0.270 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2006 | 19 | 0.270 |
Why?
|
| Base Sequence | 8 | 2007 | 1015 | 0.260 |
Why?
|
| Sp1 Transcription Factor | 1 | 2005 | 21 | 0.260 |
Why?
|
| Precipitin Tests | 2 | 2003 | 88 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 196 | 0.240 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 160 | 0.240 |
Why?
|
| Down-Regulation | 4 | 2014 | 447 | 0.230 |
Why?
|
| Cell Death | 2 | 2017 | 329 | 0.230 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating) | 1 | 2003 | 4 | 0.230 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2003 | 29 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 331 | 0.230 |
Why?
|
| Biomarkers | 3 | 2021 | 1593 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 710 | 0.230 |
Why?
|
| Cell Line | 5 | 2018 | 1752 | 0.230 |
Why?
|
| Cell Survival | 5 | 2020 | 901 | 0.230 |
Why?
|
| DNA, Single-Stranded | 2 | 2009 | 41 | 0.220 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 508 | 0.220 |
Why?
|
| Tretinoin | 1 | 2003 | 92 | 0.220 |
Why?
|
| Vincristine | 2 | 2000 | 44 | 0.220 |
Why?
|
| CRISPR-Cas Systems | 2 | 2020 | 41 | 0.210 |
Why?
|
| Liver | 2 | 2021 | 1118 | 0.210 |
Why?
|
| Blotting, Western | 6 | 2015 | 954 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 2791 | 0.210 |
Why?
|
| Enzyme Activation | 6 | 2013 | 791 | 0.210 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 37 | 0.200 |
Why?
|
| Glutamine | 2 | 2019 | 45 | 0.200 |
Why?
|
| Interleukins | 2 | 2013 | 79 | 0.200 |
Why?
|
| Female | 12 | 2021 | 38074 | 0.190 |
Why?
|
| GTP Phosphohydrolases | 2 | 2022 | 46 | 0.190 |
Why?
|
| Heterografts | 2 | 2019 | 70 | 0.190 |
Why?
|
| Radiation Tolerance | 1 | 2020 | 30 | 0.190 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 1447 | 0.180 |
Why?
|
| Cell Division | 5 | 2007 | 541 | 0.180 |
Why?
|
| Proteins | 1 | 2004 | 474 | 0.180 |
Why?
|
| Reactive Oxygen Species | 6 | 2022 | 499 | 0.180 |
Why?
|
| Plasmids | 3 | 2007 | 258 | 0.180 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.180 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 75 | 0.180 |
Why?
|
| Antibodies | 1 | 2001 | 241 | 0.180 |
Why?
|
| Male | 11 | 2021 | 37321 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2016 | 112 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2007 | 381 | 0.170 |
Why?
|
| Enzyme Inhibitors | 4 | 2014 | 659 | 0.170 |
Why?
|
| Biological Assay | 2 | 2021 | 88 | 0.170 |
Why?
|
| Flow Cytometry | 5 | 2017 | 489 | 0.170 |
Why?
|
| Colonic Neoplasms | 2 | 2015 | 299 | 0.170 |
Why?
|
| Genes, p53 | 2 | 1997 | 41 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 22 | 0.170 |
Why?
|
| Imatinib Mesylate | 2 | 2011 | 26 | 0.170 |
Why?
|
| Isoantigens | 1 | 2019 | 26 | 0.170 |
Why?
|
| Response Elements | 2 | 2016 | 29 | 0.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 43 | 0.160 |
Why?
|
| Recurrence | 3 | 2022 | 948 | 0.160 |
Why?
|
| Recombinant Proteins | 4 | 2019 | 742 | 0.160 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 138 | 0.160 |
Why?
|
| Dimerization | 1 | 2019 | 99 | 0.160 |
Why?
|
| Oogenesis | 1 | 2018 | 10 | 0.160 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 20 | 0.160 |
Why?
|
| Cell Cycle | 3 | 2022 | 312 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2019 | 95 | 0.160 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 15 | 0.160 |
Why?
|
| Golgi Apparatus | 2 | 2011 | 75 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 95 | 0.160 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 149 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 114 | 0.160 |
Why?
|
| Calcium | 3 | 2011 | 929 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1745 | 0.160 |
Why?
|
| Ovary | 1 | 2018 | 99 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 150 | 0.150 |
Why?
|
| Benzamides | 2 | 2011 | 156 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 80 | 0.150 |
Why?
|
| Smad7 Protein | 1 | 2017 | 11 | 0.150 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Hydroxamic Acids | 2 | 2010 | 84 | 0.150 |
Why?
|
| Herpesvirus 8, Human | 2 | 2014 | 24 | 0.150 |
Why?
|
| Biological Transport | 1 | 2018 | 210 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2018 | 94 | 0.150 |
Why?
|
| Alternative Splicing | 2 | 2011 | 93 | 0.150 |
Why?
|
| NAD | 1 | 2017 | 73 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2018 | 201 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 282 | 0.140 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 22 | 0.140 |
Why?
|
| NF-kappa B | 1 | 1999 | 432 | 0.140 |
Why?
|
| Dynamins | 1 | 2016 | 14 | 0.140 |
Why?
|
| Schizosaccharomyces | 1 | 2017 | 31 | 0.140 |
Why?
|
| Templates, Genetic | 1 | 1996 | 9 | 0.140 |
Why?
|
| Janus Kinase 2 | 2 | 2013 | 40 | 0.140 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 25 | 0.140 |
Why?
|
| Bacteriophage M13 | 1 | 1996 | 12 | 0.140 |
Why?
|
| Lipids | 2 | 2022 | 298 | 0.140 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2017 | 31 | 0.140 |
Why?
|
| Transplantation, Homologous | 3 | 2022 | 242 | 0.140 |
Why?
|
| Nucleotide Motifs | 1 | 2016 | 9 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 532 | 0.140 |
Why?
|
| Time Factors | 4 | 2007 | 4655 | 0.140 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 93 | 0.130 |
Why?
|
| DNA, Viral | 1 | 1996 | 114 | 0.130 |
Why?
|
| Treatment Outcome | 4 | 2017 | 7029 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 362 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 194 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 114 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2017 | 215 | 0.130 |
Why?
|
| Caspases | 3 | 2007 | 194 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2017 | 85 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2004 | 251 | 0.130 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 58 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2017 | 546 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2014 | 19 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 140 | 0.120 |
Why?
|
| Aged | 4 | 2021 | 14862 | 0.120 |
Why?
|
| Virus Latency | 1 | 2014 | 10 | 0.120 |
Why?
|
| Breast Neoplasms | 3 | 1999 | 1536 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2006 | 67 | 0.120 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2013 | 7 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2014 | 124 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 536 | 0.110 |
Why?
|
| Ethidium | 1 | 1993 | 4 | 0.110 |
Why?
|
| Luciferases | 2 | 2005 | 105 | 0.110 |
Why?
|
| Blotting, Northern | 1 | 1993 | 189 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 84 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2013 | 295 | 0.110 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2005 | 32 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2013 | 110 | 0.100 |
Why?
|
| Middle Aged | 4 | 2021 | 21147 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 116 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 163 | 0.100 |
Why?
|
| Smoothened Receptor | 1 | 2012 | 10 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 370 | 0.100 |
Why?
|
| Ubiquitins | 2 | 2022 | 22 | 0.100 |
Why?
|
| Substrate Specificity | 2 | 2017 | 234 | 0.100 |
Why?
|
| K562 Cells | 2 | 2013 | 44 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4848 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1083 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 56 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 1030 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2012 | 138 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 139 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2012 | 183 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 334 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 30 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 167 | 0.090 |
Why?
|
| RNA Interference | 4 | 2014 | 266 | 0.090 |
Why?
|
| Cycloheximide | 2 | 2001 | 50 | 0.090 |
Why?
|
| fas Receptor | 1 | 2010 | 54 | 0.090 |
Why?
|
| Binding Sites | 3 | 2017 | 631 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 1452 | 0.090 |
Why?
|
| Protein Kinase C | 2 | 2013 | 270 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2010 | 40 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2013 | 254 | 0.090 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.090 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2009 | 3 | 0.090 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 49 | 0.090 |
Why?
|
| Unfolded Protein Response | 1 | 2009 | 70 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2013 | 682 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 213 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 137 | 0.080 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2008 | 1 | 0.080 |
Why?
|
| Inositol Phosphates | 1 | 2008 | 28 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 65 | 0.080 |
Why?
|
| Adolescent | 1 | 2021 | 8912 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2014 | 174 | 0.080 |
Why?
|
| Adult | 3 | 2021 | 21403 | 0.080 |
Why?
|
| DNA Primers | 4 | 2007 | 302 | 0.080 |
Why?
|
| Th1 Cells | 2 | 2018 | 101 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2008 | 235 | 0.070 |
Why?
|
| Acetylation | 1 | 2007 | 94 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1034 | 0.070 |
Why?
|
| Larynx | 1 | 2007 | 49 | 0.070 |
Why?
|
| Fumonisins | 2 | 2009 | 14 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2004 | 200 | 0.070 |
Why?
|
| Pharynx | 1 | 2007 | 89 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 93 | 0.070 |
Why?
|
| Th17 Cells | 2 | 2017 | 116 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 282 | 0.070 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 274 | 0.070 |
Why?
|
| Catalytic Domain | 2 | 2022 | 99 | 0.070 |
Why?
|
| RNA, Antisense | 2 | 1998 | 25 | 0.070 |
Why?
|
| Inactivation, Metabolic | 1 | 2006 | 28 | 0.070 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2006 | 3 | 0.070 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2006 | 5 | 0.070 |
Why?
|
| Maximum Tolerated Dose | 1 | 2006 | 41 | 0.070 |
Why?
|
| Acylation | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cations | 1 | 2006 | 51 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 134 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2006 | 40 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 369 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2006 | 282 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 14 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 170 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 52 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 132 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 492 | 0.060 |
Why?
|
| Trypan Blue | 1 | 2004 | 24 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 446 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 322 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2004 | 66 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 1056 | 0.060 |
Why?
|
| Silver Staining | 1 | 2003 | 11 | 0.060 |
Why?
|
| Thiazoles | 1 | 2004 | 95 | 0.060 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 50 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 2002 | 50 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1033 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 144 | 0.060 |
Why?
|
| Chromatin | 1 | 2003 | 76 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1553 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 130 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 626 | 0.050 |
Why?
|
| Coat Protein Complex I | 1 | 2022 | 3 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 246 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 261 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 29 | 0.050 |
Why?
|
| Mitochondrial Dynamics | 1 | 2022 | 17 | 0.050 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 50 | 0.050 |
Why?
|
| Catalysis | 1 | 2022 | 123 | 0.050 |
Why?
|
| Polyploidy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2022 | 33 | 0.050 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2021 | 3 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2022 | 150 | 0.050 |
Why?
|
| Metabolome | 1 | 2021 | 15 | 0.050 |
Why?
|
| Genes, myc | 1 | 2001 | 26 | 0.050 |
Why?
|
| Half-Life | 1 | 2001 | 96 | 0.050 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2001 | 11 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2001 | 22 | 0.050 |
Why?
|
| Cholic Acids | 1 | 2001 | 8 | 0.050 |
Why?
|
| Daunorubicin | 1 | 2001 | 20 | 0.050 |
Why?
|
| Glucosyltransferases | 1 | 2001 | 28 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 39 | 0.050 |
Why?
|
| G1 Phase | 1 | 2001 | 42 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 6 | 0.050 |
Why?
|
| Glucosylceramides | 1 | 2001 | 32 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2021 | 106 | 0.050 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 51 | 0.050 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 17 | 0.050 |
Why?
|
| Models, Biological | 2 | 2020 | 981 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2001 | 191 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 247 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 226 | 0.050 |
Why?
|
| Organoids | 1 | 2020 | 42 | 0.050 |
Why?
|
| X-Rays | 1 | 2020 | 56 | 0.050 |
Why?
|
| Cholesterol | 1 | 2022 | 331 | 0.050 |
Why?
|
| Peptides | 1 | 2003 | 455 | 0.050 |
Why?
|
| Gene Editing | 1 | 2020 | 33 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 266 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 136 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2000 | 16 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 73 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Phenformin | 1 | 2019 | 3 | 0.040 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2019 | 16 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Glutaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2019 | 7 | 0.040 |
Why?
|
| L-Selectin | 1 | 2019 | 28 | 0.040 |
Why?
|
| Benzeneacetamides | 1 | 2019 | 11 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 32 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 1999 | 47 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2019 | 75 | 0.040 |
Why?
|
| Metformin | 1 | 2019 | 63 | 0.040 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2018 | 18 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 260 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 135 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2018 | 104 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Paclitaxel | 1 | 1998 | 140 | 0.040 |
Why?
|
| Diet | 1 | 2021 | 514 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 88 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 1998 | 312 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 1266 | 0.040 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 127 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2017 | 47 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 100 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 222 | 0.040 |
Why?
|
| Codon | 1 | 1997 | 21 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 199 | 0.040 |
Why?
|
| Nausea | 1 | 2017 | 47 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1997 | 67 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 397 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 95 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2018 | 239 | 0.040 |
Why?
|
| Spleen | 1 | 2017 | 301 | 0.040 |
Why?
|
| Vomiting | 1 | 2017 | 56 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 57 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 304 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1997 | 89 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1996 | 16 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 89 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2009 | 36 | 0.030 |
Why?
|
| Fatigue | 1 | 2017 | 132 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 420 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1995 | 11 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 301 | 0.030 |
Why?
|
| Imidazoles | 1 | 2016 | 175 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 10 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2014 | 15 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2015 | 77 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2015 | 130 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 76 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 2 | 2006 | 36 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2014 | 38 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 69 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 56 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 81 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 511 | 0.030 |
Why?
|
| Enzyme Activators | 1 | 2013 | 14 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2013 | 8 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1993 | 2 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 6 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1993 | 32 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 100 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 18 | 0.030 |
Why?
|
| beta Catenin | 1 | 2013 | 73 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1993 | 144 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2013 | 39 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 57 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 100 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 294 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2013 | 289 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2358 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 706 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 268 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2013 | 291 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 384 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3705 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 411 | 0.020 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 31 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 31 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 514 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 149 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2673 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1047 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2010 | 219 | 0.020 |
Why?
|
| Fenretinide | 1 | 2007 | 26 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 92 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 138 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 5717 | 0.020 |
Why?
|
| Myeloblastin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 48 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2002 | 73 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 85 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 86 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 160 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 2002 | 22 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Marine Toxins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Oxazoles | 1 | 2002 | 17 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 2002 | 24 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2002 | 36 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2001 | 18 | 0.010 |
Why?
|
| Colforsin | 1 | 2001 | 42 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 250 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1995 | 14 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1995 | 11 | 0.010 |
Why?
|
| Ethanol | 1 | 1995 | 893 | 0.010 |
Why?
|